PUMA BIOTECHNOLOGY, INC. (PBYI) has 5 SEC Form 4 insider filings on record in the last 90 days. No insider purchases were filed — 5 sales totalling $1.3M. Most recent filing: Sept. 16, 2026.
| Date | Insider | Value | Shares | Stake | Pre-planned | Links |
|---|---|---|---|---|---|---|
| Sept. 16, 2026 filed Sept. 14, 2026 | WILSON TROY EDWARD Director | −$45,500 | 5,000 | −8% | Yes | |
|
|
||||||
| Sept. 16, 2026 filed Sept. 14, 2026 | Cesano Alessandra Director | −$110,844 | 162,150 | −20% | Yes | |
|
|
||||||
| July 8, 2026 filed July 6, 2026 | AUERBACH ALAN H President and CEO | −$364,051 | 44,058 | −1% | Yes | |
|
|
||||||
| July 8, 2026 filed July 6, 2026 | HUNT DOUGLAS M See Remarks | −$69,905 | 8,460 | −4% | Yes | |
|
|
||||||
| July 8, 2026 filed July 6, 2026 | NOUGUES MAXIMO F Chief Financial Officer | −$77,557 | 9,386 | −4% | Yes | |
|
|
||||||
Form 4 is the filing company officers, directors and 10% shareholders must submit to the SEC within two business days of trading their own company's stock. Open-market purchases generally carry more signal than sales, which are often scheduled in advance. More on how this works.
Real-time Telegram alerts the moment a Form 4 is filed. Filings shown here are delayed by 72 hours.
Start free